ENSG vs TECH: fair value comparison
The Ensign Group, Inc. and Bio-Techne Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TECH currently sits closer to the top of our discount ranking. TECH carries the stronger quality grade.
| ENSG | TECH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $173.20 | $72.12 |
| 12-month range | $164.82–$215.67 | $50.79–$72.18 |
| Sector rank | #56 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | D | A |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Stable |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Uptrend |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: ENSG fair value analysis · TECH fair value analysis